Thunder Bay's health sciences community has attracted two prized recruits to expand research and commercialization opportunities.
Dr. Mitchell Albert from Harvard University was named the first research chair for Lakehead University and the Thunder Bay Regional Research Institute (TBRRI).
He holds a PhD in physical chemistry and was a Harvard faculty member in Boston. Albert, who moved to Thunder Bay this past summer, is an expert in advanced MRI technique used to image the brain and lungs.
He'll be a faculty member with Lakehead's chemistry department and will teach in the new PhD program in chemistry and materials science.
Halifax's Scott Gillis brings 21 years of experience in the pharmaceutical and health industry to northwestern Ontario where he'll hold down the dual roles as director of business development and commercialization for both TBRRI and MaRS Innovation in Toronto.
Gillis spent most of his career in management at GlaxoSmithKline. He'll be working to commercialize research projects at the institute, especially on the medical isotopes front.
Institute CEO Michael Power said the announcement is an example of how key partnerships in Thunder Bay's medical community “are attracting scientists and business leaders to the North.”
.jpeg;w=120;h=80;mode=crop)
